MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on October 7, 2005; DOI: 10.1124/mol.105.018705


This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Erratum
Right arrow All Versions of this Article:
mol.105.018705v1
69/1/140    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tijet, N.
Right arrow Articles by Pohjanvirta, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tijet, N.
Right arrow Articles by Pohjanvirta, R.


Received for publication September 8, 2005.
Revised October 3, 2005.
Accepted for publication October 7, 2005.

The aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries

Nathalie Tijet 1, Paul C Boutros 1, Ivy D Moffat 1, Allan B. Okey 1*, Jouko Tuomisto 2, Raimo Pohjanvirta 3

1 University of Toronto 2 National Public Health Institute, Finland 3 University of Helsinki

* Address correspondence to: E-mail: allan.okey{at}utoronto.ca

Abstract

ABSTRACT Conventional biochemical and molecular techniques previously identified several genes whose expression is regulated by the aryl hydrocarbon receptor (AHR). We sought to map the complete spectrum of AHR-dependent genes in adult liver using expression arrays to contrast mRNA profiles in Ahr-null mice (Ahr-/-) with those in mice with wildtype AHR (Ahr+/+). Transcript profiles were determined both in untreated mice and in mice treated 19 hours earlier with 1000 µg/kg of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Expression of 456 ProbeSets was significantly altered by TCDD in an AHR-dependent manner, including members of the classical AHRE-I gene battery such as Cyp1a1, Cyp1a2, Cyp1b1 and Nqo1. In the absence of exogenous ligand, AHR status alone affected expression of 392 ProbeSets, suggesting that the AHR has multiple functions in normal physiology. In Ahr-/-, only 32 ProbeSets exhibited responses to TCDD, indicating that the AHR is required for virtually all transcriptional responses to dioxin exposure in liver. The flavin-containing monooxygenases, Fmo2 and Fmo3, previously considered uninducible, were highly induced by TCDD in an AHR-dependent manner. Intriguingly, the estrogen receptor alpha as well as two estrogen-receptor-related genes (alpha and gamma) exhibit AHR-dependent expression, thereby extending cross-talk opportunities between the intensively-studied AHR and ER pathways. p53 binding sites are over-represented in genes downregulated by TCDD suggesting that TCDD inhibits p53 transcriptional activity. Overall, our study identifies a wide range of genes that depend on the AHR either for constitutive expression or for response to TCDD.


Key words: Sex hormones, Regulation of gene expression, Cytochrome P450, Flavin monooxygenases, Regulation - transcriptional, Regulation - xenobiotic, Ah receptor, Toxicant-induced gene express


This article has been cited by other articles:


Home page
Toxicol SciHome page
P. C. Boutros, K. A. Bielefeld, R. Pohjanvirta, and P. A. Harper
Dioxin-Dependent and Dioxin-Independent Gene Batteries: Comparison of Liver and Kidney in AHR-Null Mice
Toxicol. Sci., November 1, 2009; 112(1): 245 - 256.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
R. L. Yeager, S. A. Reisman, L. M. Aleksunes, and C. D. Klaassen
Introducing the "TCDD-Inducible AhR-Nrf2 Gene Battery"
Toxicol. Sci., October 1, 2009; 111(2): 238 - 246.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. M. Novick, A. M. Mitzey, M. S. Brownfield, and A. A. Elfarra
Differential Localization of Flavin-Containing Monooxygenase (FMO) Isoforms 1, 3, and 4 in Rat Liver and Kidney and Evidence for Expression of FMO4 in Mouse, Rat, and Human Liver and Kidney Microsomes
J. Pharmacol. Exp. Ther., June 1, 2009; 329(3): 1148 - 1155.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
K. M. Kransler, B. P. McGarrigle, D. D. Swartz, and J. R. Olson
Lung Development in the Holtzman Rat is Adversely Affected by Gestational Exposure to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin
Toxicol. Sci., February 1, 2009; 107(2): 498 - 511.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
T. Celius, S. Roblin, P. A. Harper, J. Matthews, P. C. Boutros, R. Pohjanvirta, and A. B. Okey
Aryl Hydrocarbon Receptor-Dependent Induction of Flavin-Containing Monooxygenase mRNAs in Mouse Liver
Drug Metab. Dispos., December 1, 2008; 36(12): 2499 - 2505.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
R. M. Novick and A. A. Elfarra
Purification and Characterization of Flavin-Containing Monooxygenase Isoform 3 from Rat Kidney Microsomes
Drug Metab. Dispos., December 1, 2008; 36(12): 2468 - 2474.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
T. Simon, C. R. Kirman, L. L. Aylward, R. A. Budinsky, J. C. Rowlands, and T. F. Long
Estimates of Cancer Potency of 2,3,4,7,8-Pentachlorodibenzofuran Using Both Nonlinear and Linear Approaches
Toxicol. Sci., December 1, 2008; 106(2): 519 - 537.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
Y. C. M. Staal, D. S. Pushparajah, M. H. M. van Herwijnen, R. W. H. Gottschalk, L. M. Maas, C. Ioannides, F. J. van Schooten, and J. H. M. van Delft
Interactions between polycyclic aromatic hydrocarbons in binary mixtures: Effects on gene expression and DNA adduct formation in precision-cut rat liver slices
Mutagenesis, November 1, 2008; 23(6): 491 - 499.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
R. M. Sawaya and D. S. Riddick
Cytochrome P450 2C11 5'-Flanking Region and Promoter Mediate in Vivo Suppression by 3-Methylcholanthrene
Drug Metab. Dispos., September 1, 2008; 36(9): 1803 - 1811.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
A. Hudder and R. F. Novak
miRNAs: Effectors of Environmental Influences on Gene Expression and Disease
Toxicol. Sci., June 1, 2008; 103(2): 228 - 240.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. B. Silkworth, E. A. Carlson, C. McCulloch, K. Illouz, S. Goodwin, and T. R. Sutter
Toxicogenomic Analysis of Gender, Chemical, and Dose Effects in Livers of TCDD- or Aroclor 1254-Exposed Rats Using a Multifactor Linear Model
Toxicol. Sci., April 1, 2008; 102(2): 291 - 309.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
H. Sarioglu, S. Brandner, M. Haberger, C. Jacobsen, J. Lichtmannegger, M. Wormke, and U. Andrae
Analysis of 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced Proteome Changes in 5L Rat Hepatoma Cells Reveals Novel Targets of Dioxin Action Including the Mitochondrial Apoptosis Regulator VDAC2
Mol. Cell. Proteomics, February 1, 2008; 7(2): 394 - 410.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
A. C. Aragon, P. G. Kopf, M. J. Campen, J. K. Huwe, and M. K. Walker
In Utero and Lactational 2,3,7,8-Tetrachlorodibenzo-p-dioxin Exposure: Effects on Fetal and Adult Cardiac Gene Expression and Adult Cardiac and Renal Morphology
Toxicol. Sci., February 1, 2008; 101(2): 321 - 330.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Shin, N. Wakabayashi, V. Misra, S. Biswal, G. H. Lee, E. S. Agoston, M. Yamamoto, and T. W. Kensler
NRF2 Modulates Aryl Hydrocarbon Receptor Signaling: Influence on Adipogenesis
Mol. Cell. Biol., October 15, 2007; 27(20): 7188 - 7197.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
I. D. Moffat, P. C. Boutros, T. Celius, J. Linden, R. Pohjanvirta, and A. B. Okey
microRNAs in Adult Rodent Liver Are Refractory to Dioxin Treatment
Toxicol. Sci., October 1, 2007; 99(2): 470 - 487.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
I. D. Moffat, S. Roblin, P. A. Harper, A. B. Okey, and R. Pohjanvirta
Aryl Hydrocarbon Receptor Splice Variants in the Dioxin-Resistant Rat: Tissue Expression and Transactivational Activity
Mol. Pharmacol., October 1, 2007; 72(4): 956 - 966.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
A. B. Okey
An Aryl Hydrocarbon Receptor Odyssey to the Shores of Toxicology: The Deichmann Lecture, International Congress of Toxicology-XI
Toxicol. Sci., July 1, 2007; 98(1): 5 - 38.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
C. G. Woods, J. P. Vanden Heuvel, and I. Rusyn
Genomic Profiling in Nuclear Receptor-Mediated Toxicity
Toxicol Pathol, June 1, 2007; 35(4): 474 - 494.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. B. Koukouritaki, M. T. Poch, M. C. Henderson, L. K. Siddens, S. K. Krueger, J. E. VanDyke, D. E. Williams, N. M. Pajewski, T. Wang, and R. N. Hines
Identification and Functional Analysis of Common Human Flavin-Containing Monooxygenase 3 Genetic Variants
J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 266 - 273.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
B. J. Ovando, C. M. Vezina, B. P. McGarrigle, and J. R. Olson
Hepatic Gene Downregulation following Acute and Subchronic Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin
Toxicol. Sci., December 1, 2006; 94(2): 428 - 438.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
R. Pastorelli, D. Carpi, R. Campagna, L. Airoldi, R. Pohjanvirta, M. Viluksela, H. Hakansson, P. C. Boutros, I. D. Moffat, A. B. Okey, et al.
Differential Expression Profiling of the Hepatic Proteome in a Rat Model of Dioxin Resistance: CORRELATION WITH GENOMIC AND TRANSCRIPTOMIC ANALYSES
Mol. Cell. Proteomics, May 1, 2006; 5(5): 882 - 894.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
R. Ishimura, T. Kawakami, S. Ohsako, K. Nohara, and C. Tohyama
Suppressive Effect of 2,3,7,8-Tetrachlorodibenzo-p-dioxin on Vascular Remodeling That Takes Place in the Normal Labyrinth Zone of Rat Placenta during Late Gestation
Toxicol. Sci., May 1, 2006; 91(1): 265 - 274.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics